Stryker Corporation Total Assets

Latest as of June 2026: $47.93 Billion USD

Stryker Corporation total assets. Based on the latest financial reports, Stryker Corporation (SYK) holds total assets worth $47.93 Billion USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Stryker Corporation (SYK) total market value for the company's overall valuation and market capitalisation.

Total Assets of Stryker Corporation (1985–2025)

Total assets of Stryker Corporation from 1985 to 2025. This chart illustrates how Stryker Corporation's total assets have evolved over time, based on quarterly financial data. See today's stock price for Stryker Corporation for real-time trading data and today's change.

Stryker Corporation - Asset Composition Analysis

Stryker Corporation Total Assets Breakdown (December 2025)

Stryker Corporation total assets breakdown as of December 2025. Stryker Corporation's total assets of $47.93 Billion consist of 30.8% current assets and 69.2% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $4.01 Billion 8.4%
Accounts Receivable $4.04 Billion 8.4%
Inventory $5.31 Billion 11.1%
Property, Plant & Equipment $3.88 Billion 8.1%
Intangible Assets $5.68 Billion 11.9%
Goodwill $19.29 Billion 40.3%

Asset Composition Trend (1985–2025)

This chart illustrates how Stryker Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is Stryker Corporation's working capital to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Stryker Corporation's current assets represent 30.8% of total assets in 2025, a decrease from 76.5% in 1985.
  • Cash Position: Cash and equivalents constituted 8.4% of total assets in 2025, down from 17.1% in 1985.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 51.0% of total assets, an increase from 1.0% in 1985.
  • Asset Diversification: The largest asset category is goodwill at 40.3% of total assets.

Stryker Corporation Competitors by Total Assets

Key competitors of Stryker Corporation based on total assets are shown below.

Company Country Total Assets
Shenzhen New Industries Biomedical
SHE:300832
China CN¥9.58 Billion
GN Store Nord
CO:GN
Denmark Dkr29.23 Billion
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212
China CN¥1.86 Billion
Polynovo Ltd
AU:PNV
Australia AU$123.37 Million
L&C Bio Co. Ltd
KQ:290650
Korea ₩497.94 Billion
VIROMED MEDICAL NA O.N.
XETRA:VME
Germany €13.91 Million
Affluent Medical SAS
PA:AFME
France €59.84 Million
DRGEM Corporation
KQ:263690
Korea ₩131.65 Billion

Stryker Corporation - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 2.16 1.78 2.13
Quick Ratio 1.33 1.06 1.35
Cash Ratio 0.00 0.33 0.58
Working Capital $7.73 Billion $5.71 Billion $5.01 Billion

Stryker Corporation - Advanced Valuation Insights

This section examines the relationship between Stryker Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 5.42
Latest Market Cap to Assets Ratio 2.34
Asset Growth Rate (YoY) 11.3%
Total Assets $47.84 Billion
Market Capitalization $111.95 Billion USD

Valuation Analysis

Premium Asset Valuation: The market values Stryker Corporation's assets at a significant premium (2.34x), suggesting investors see substantial growth potential or unique competitive advantages.

Rapid Asset Growth: Stryker Corporation's assets grew by 11.3% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Stryker Corporation (1985–2025)

The table below shows the annual total assets of Stryker Corporation from 1985 to 2025.

Year Total Assets Change
2025-12-31 $47.84 Billion +11.34%
2024-12-31 $42.97 Billion +7.66%
2023-12-31 $39.91 Billion +8.21%
2022-12-31 $36.88 Billion +6.51%
2021-12-31 $34.63 Billion +0.88%
2020-12-31 $34.33 Billion +13.80%
2019-12-31 $30.17 Billion +10.79%
2018-12-31 $27.23 Billion +22.75%
2017-12-31 $22.18 Billion +8.55%
2016-12-31 $20.43 Billion +25.78%
2015-12-31 $16.25 Billion -8.28%
2014-12-31 $17.71 Billion +12.51%
2013-12-31 $15.74 Billion +16.90%
2012-12-31 $13.47 Billion +8.56%
2011-12-31 $12.40 Billion +13.86%
2010-12-31 $10.90 Billion +20.11%
2009-12-31 $9.07 Billion +19.31%
2008-12-31 $7.60 Billion +3.39%
2007-12-31 $7.35 Billion +25.20%
2006-12-31 $5.87 Billion +18.80%
2005-12-31 $4.94 Billion +21.07%
2004-12-31 $4.08 Billion +29.27%
2003-12-31 $3.16 Billion +12.20%
2002-12-31 $2.82 Billion +16.17%
2001-12-31 $2.42 Billion -0.30%
2000-12-31 $2.43 Billion -5.80%
1999-12-31 $2.58 Billion -10.58%
1998-12-31 $2.89 Billion +192.96%
1997-12-31 $985.10 Million -0.85%
1996-12-31 $993.50 Million +16.21%
1995-12-31 $854.90 Million +11.32%
1994-12-31 $768.00 Million +69.09%
1993-12-31 $454.20 Million +33.47%
1992-12-31 $340.30 Million +25.90%
1991-12-31 $270.30 Million +29.02%
1990-12-31 $209.50 Million +37.56%
1989-12-31 $152.30 Million +22.04%
1988-12-31 $124.80 Million +18.86%
1987-12-31 $105.00 Million +22.09%
1986-12-31 $86.00 Million +21.64%
1985-12-31 $70.70 Million --

About Stryker Corporation

NYSE:SYK USA Medical Devices
Market Cap
$111.95 Billion
Market Cap Rank
#215 Global
#115 in USA
Share Price
$291.86
Change (1 day)
-6.38%
52-Week Range
$269.75 - $387.46
All Time High
$403.53
About

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment … Read more